1567360-62-6

Basic information

• Product Name: 2,3-dichloro-N-(4-methoxybenzyl)-4-(piperazin-1-yl)aniline
• Synonyms: 2,3-dichloro-N-(4-methoxybenzyl)-4-(piperazin-1-yl)aniline
• CAS NO: 1567360-62-6
• Molecular Weight: 366.29
• Mol File: 1567360-62-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,3-dichloro-N-(4-methoxybenzyl)-4-(piperazin-1-yl)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dichloro-N-(4-methoxybenzyl)-4-(piperazin-1-yl)aniline(1567360-62-6)
• EPA Substance Registry System: 2,3-dichloro-N-(4-methoxybenzyl)-4-(piperazin-1-yl)aniline(1567360-62-6)

Safety Data

• Hazardous Substances Data: 1567360-62-6(Hazardous Substances Data)

Upstream product

• 110-85-0 piperazine 
• 1567360-63-7 4-bromo-2,3-dichloro-N-(4-methoxybenzyl)aniline 
• 56978-48-4 4-bromo-2,3-dichloro-phenylamine 
• 824-94-2 p-methoxybenzyl chloride 
• 7664-41-7 ammonia 
• 865-48-5 sodium t-butanolate 

Downstream Products

• 1567360-64-8 2,3-dichloro-4-(piperazin-1-yl)aniline 
• 1567360-61-5 7-(4-(4-(4-amino-2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one 
• 1567360-65-9 4-((2,3-dichloro-4-(4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazin-1-yl)phenyl)amino)-4-oxobutanoic acid 
• 1567360-66-0 5-((2,3-dichloro-4-(4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazin-1-yl)phenyl)amino)-5-oxopentanoic acid 

Relevant articles and documents

Antibodies to aripiprazole haptens and use thereof

Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, in

Antibodies to Aripiprazole Haptens and Use Thereof

Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, in